Kuniharu Ishiki

The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease

Y. Shiratori, K. Yokota, H. Okada, 2005, The American Journal of Gastroenterology.

The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori

Kazuhide Yamamoto, K. Yokota, H. Okada, 2011, Journal of Gastroenterology.

GASTRIC ADENOCARCINOMA OF FUNDIC GLAND TYPE (CHIEF CELL PREDOMINANT TYPE) TREATED WITH ENDOSCOPIC ASPIRATION MUCOSECTOMY

T. Yao, K. Ishiki, Haruka Miyoshi, 2011, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease.

Y. Shiratori, Kazuhide Yamamoto, K. Yokota, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Interleukin-1β genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection

Y. Shiratori, Kazuhide Yamamoto, K. Yokota, 2003, American Journal of Gastroenterology.

Reinfection rate following effective therapy against Helicobacter pylori infection in Japan

K. Yokota, T. Tsuji, M. Mizuno, 2002, Journal of gastroenterology and hepatology.

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism

K. Yokota, M. Mizuno, J. Nasu, 2001, Journal of gastroenterology and hepatology.

Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication

K. Yokota, H. Okada, M. Mizuno, 2019, Journal of Gastroenterology.

Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study

Kazuhide Yamamoto, K. Yokota, H. Okada, 2015, Journal of Gastroenterology.

Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan

Kazuhide Yamamoto, K. Yokota, H. Okada, 2012, Journal of Gastroenterology.

Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.

Y. Shiratori, Kazuhide Yamamoto, K. Yokota, 2003, The American journal of gastroenterology.